gvtcx

Next Generation Sequencing Panel for Analysis of Familial Hypercholesterolemia

key details

Statuscomplete
Category (CPV) 38430000 +1 more
RegionWales
Deadline21 Apr 2023
Procedureopen
OCIDocds-h6vhtk-03b49b

Award

SupplierValueDateStatus
Nonacus Ltd · · active

description

Familial Hypercholesterolemia (FH) diagnosis is undertaken in Wales by inhouse laboratories under the All-Wales Medical Genomics Service (AWMGS) umbrella. To undertake testing, the All-Wales Genomics Laboratory (AWGL) require a library preparation solution for diagnostic screening for FH patients.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
21 Mar 2023 Contract notice (F02) Earlier regulations 008112-2023
11 Apr 2024 Contract award notice (F03) Earlier regulations 011739-2024

more from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Sell2Wales. Contact details for named individuals are not reproduced on this site.